Lipid Nanoparticles to enable engineering or ablation of pathogenic cells in the body
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
713
NCT01098981
Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke
Phase: Phase 3
Role: Lead Sponsor
Start: May 31, 2013
Completion: Apr 30, 2015
NCT06917742
A Study of CPTX2309 in Healthy Participants
Phase: Phase 1
Start: Apr 9, 2025
Completion: Feb 28, 2026
Loading map...